Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Mol Cancer Ther. 2017 Mar 6;16(6):1114–1123. doi: 10.1158/1535-7163.MCT-16-0541

Table 1.

Hematologic parameters after twice weekly EPHARNA administration in mice. EPHARNA appeared to cause a mild, dose dependent inflammatory response.

EPHARNA dose group
0 mg/kg 0.3 mg/kg 0.6 mg/kg
Male (n=4) Female (n=5) Male (n=5) Female (n=5) Male (n=4) Female (n=5)
WBC (SD) 5.720 (1.220) 7.382 (1.759) 5.840 (1.208) 8.332 (1.018) 8.734 (1.656) 8.636 (2.840)
Absolute Neutrophil 0.888 (0.253) 0.908 (0.205) 0.854 (0.148) 1.170 (0.290) 1.076 (0.212) 1.200 (0.401)
Absolute Monocyte 0.175 (0.083) 0.282 (0.217) 0.290 (0.135) 0.774 (0.240) 0.524 (0.271) 0.840 (0.215)
Absolute Lymphocyte 4.535 (1.274) 6.036 (1.906) 4.552 (1.041) 6.092 (0.768) 6.958 (1.500) 6.302 (2.558)
Absolute Eosinophil 0.116 (0.111) 0.154 (0.127) 0.146 (0.036) 0.296 (0.231) 0.178 (0.269) 0.278 (0.216)
RBC 9.67 (0.261) 9.35 (0.664) 9.52 (0.289) 9.19 (0.493) 9.70 (0.440) 9.12 (0.210)
Hgb 15.1 (0.46) 14.9 (1.03) 15.44 (0.61) 14.76 (0.85) 15.30 (0.58) 14.30 (0.71)
HCT 52.0 (1.30) 50.2 (2.96) 52.1 (1.15) 49.4 (2.70) 51.1 (1.70) 46.92 (1.94)
MFCV 53.85 (0.97) 53.74 (0.94) 54.70 (1.15) 53.78 (1.09) 52.72 (0.55) 51.46 (0.40)
MCHC 15.63 (0.26) 15.98 (0.49) 16.18 (0.33) 16.08 (0.45) 15.76 (0.55) 15.66 (0.58)